Insmed (INSM) PT Lowered to $207 at BofA Securities

October 12, 2026 6:16 AM

BofA Securities analyst Jason Zemansky lowered the price target on Insmed (NASDAQ: INSM) to $207.00 (from $214.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found